Transcription of Annex 9 Guidelines on packaging for pharmaceutical …
{{id}} {{{paragraph}}}
119 World Health OrganizationWHO Technical Report Series, No. 902, 2002 Annex 9 Guidelines on packaging for pharmaceuticalproductsIntroductory of of and , relabelling and inserts for patients (patient information leaflets) of of materials and of or types of assurance aspects of and of of the in The international for dosage form requirements for containers in Europe, Japanand the Standards145 References145 Bibliography147 Appendix 1 Storage areas150 Appendix 2 Labels151 Appendix 3 Self-inspection and quality audits152 Appendix 4 International Standards on packaging154 Introductory noteThis review of the various elements of the packaging of a pharmaceu-tical product is aimed at ensuring that medicines arrive safely in thehands of the patients for whom they are the manufacture of pharmaceutical products.
122 General bulk product Any product that has completed all the processing stages up to, but not including, final packaging (1).containers A container for pharmaceutical …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Stability testing of pharmaceutical products, Pharmaceutical, GUIDELINES, Products, Guidelines for Good Clinical Practice, Pharmaceutical products, Stability testing of active pharmaceutical, Medicinal products quality, safety and efficacy, Medicinal products – quality, safety and efficacy, Pharmaceutical Administration and Regulations in, REGISTRATION